» Authors » Laura Ravani

Laura Ravani

Explore the profile of Laura Ravani including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 259
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
de Toledo L, Rosseto H, Ravani L, Cortesi R, Bruschi M
Curr Drug Deliv . 2015 Nov; 13(7):1152-1164. PMID: 26563943
Metronidazole is an antimicrobial agent utilized for the treatment of protozoa and anaerobic bacteria infections. Many times, it is necessary to modify the metronidazole release, and the development of modified...
2.
Cortesi R, Damiani C, Ravani L, Marvelli L, Esposito E, Drechsler M, et al.
Int J Pharm . 2015 Jul; 492(1-2):291-300. PMID: 26187165
The aliphatic phosphine PTA (1,3,5-triaza-7-phosphaadamantane) is a promising ligand for metal complexes designed and developed as innovative inorganic drugs. In the present paper, an N-alkylated derivative of PTA, (PTAC16H33)X (X=I,...
3.
Esposito E, Sticozzi C, Ravani L, Drechsler M, Muresan X, Cervellati F, et al.
Exp Dermatol . 2015 Mar; 24(6):449-54. PMID: 25808217
This study describes the production and characterization of nanostructured lipid dispersions (NLDs) containing curcumin (CUR) as new tools for curcumin topical delivery. Four types of NLDs based on monoolein in...
4.
Esposito E, Ravani L, Drechsler M, Mariani P, Contado C, Ruokolainen J, et al.
Mater Sci Eng C Mater Biol Appl . 2015 Jan; 48:328-36. PMID: 25579930
This study describes the preparation, characterization, and in vivo evaluation in rats of nanostructured lipid carriers (NLCs) encapsulating rimonabant (RMN) as prototypical cannabinoid antagonist. A study was conducted in order...
5.
Ravani L, Sarpietro M, Esposito E, Di Stefano A, Sozio P, Calcagno M, et al.
Mater Sci Eng C Mater Biol Appl . 2015 Jan; 48:294-300. PMID: 25579926
This paper describes the production, characterization and in vivo activity of lipid nanocarriers (LN) containing a levodopa prodrug (LD-PD) with therapeutic potential in Parkinson's disease. LD is the mainstay of...
6.
Esposito E, Boschi A, Ravani L, Cortesi R, Drechsler M, Mariani P, et al.
Eur J Pharm Biopharm . 2014 Dec; 89:145-56. PMID: 25497177
This study describes the preparation, characterization, and biodistribution of radiolabelled nanostructured lipid carriers (NLCs) especially designed for in vivo tomographic study. A preliminary formulative study was conducted in order to...
7.
Esposito E, Ravani L, Contado C, Costenaro A, Drechsler M, Rossi D, et al.
Mater Sci Eng C Mater Biol Appl . 2014 Nov; 33(1):411-8. PMID: 25428089
In this study a formulation suitable to be applied on oral and/or vaginal mucosa has been developed for the treatment of fungal infections. The aim of the research is a...
8.
Ferraro L, Beggiato S, Borroto-Escuela D, Ravani L, OConnor W, Tomasini M, et al.
Curr Protein Pept Sci . 2014 Sep; 15(7):681-90. PMID: 25175457
The tridecapeptide neurotensin (NT) acts as neurotransmitter in the central nervous system and in the periphery. NT and NT receptors are largely localized in dopamine (DA)-enriched regions of the mammalian...
9.
Esposito E, Ravani L, Mariani P, Huang N, Boldrini P, Drechsler M, et al.
Eur J Pharm Biopharm . 2013 Dec; 86(2):121-32. PMID: 24361485
The present study describes the production and characterization of monoolein aqueous dispersions (MAD) and lecithin organogels (ORG) as percutaneous delivery systems for curcumin (CUR). In particular, MAD stabilized by sodium...
10.
Cortesi R, Campioni M, Ravani L, Drechsler M, Pinotti M, Esposito E
N Biotechnol . 2013 Oct; 31(1):44-54. PMID: 24120492
Solid lipid nanoparticles (SLNs) consisting of tristearin or tribehenin, and monoolein aqueous dispersions (MADs) consisting of glyceryl-monoolein have been studied as potential nanocarriers for nucleic acids. The cationic character of...